woundcare - Bonvadis®

Tag

woundcare

•2025-05-21•Nelly Wang•News

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds for Australia.

Oneness has received notification from the agent today that the product topical cream received medical device marketing authorization approval for all indications in wounds under ARTG certificate number DV-2025-MC-09357-1 and with permission to be marketed in the Australia.

Recent articles

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by COFEPRIS in Mexico. 2025-10-03
The medical device registration application of Bonvadis® for all indications in wounds has been accepted by ThaiFDA. 2025-10-03
2025 International Diabetic Foot Course Form 2025-09-17
Oneness Biotech to participate in the 16th International Diabetic Foot Course 2025 2025-09-12
Expert Talks – Meet Dr. Chia-Ding Shih, DPM on September 5th 1:00 PM at SAWC Fall 2025 2025-09-02
Expert Talks – Meet Dr. Daniel L. Kapp, MD on September 4th 5:30 PM at SAWC Fall 2025 2025-09-02
Oneness Biotech to Exhibit at the Symposium on Advanced Wound Care (SAWC) Fall 2025 2025-09-02

Bonvadis^® is a topical product containing proprietary natural herbal ingredients for wound bed optimization and healing, enabling fast healing in simplicity.

The combination of “Bon” (‘good’ in French) and “vadízo̱” (‘walk’ in Greek) is the origination of the Bonvadis^® product name, representing Oneness’ confidence in restoring patients’ ability to walk (limb salvage).

..

About Us
Tel : +886-2-2703-1098 (Taiwan)
Fax : +886-2-2703-1200
Email : bonvadis@onenessbio.com.tw
Add : 35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City, Taiwan (R.O.C.)

YouTube
LinkedIn
Link